File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1080/01443615.2019.1581740
- Scopus: eid_2-s2.0-85064610557
- PMID: 31006301
- WOS: WOS:000469530300001
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Efficacy and safety of ultrasound-guided high-intensity focused ultrasound for uterine fibroids: a preliminary experience
Title | Efficacy and safety of ultrasound-guided high-intensity focused ultrasound for uterine fibroids: a preliminary experience |
---|---|
Authors | |
Keywords | Fibroid high-intensity focussed ultrasound ultrasound-guided |
Issue Date | 2019 |
Publisher | Taylor & Francis: STM, Behavioural Science and Public Health Titles. The Journal's web site is located at http://informahealthcare.com/journal/jog |
Citation | Journal of Obstetrics and Gynaecology, 2019, v. 39, p. 833-839 How to Cite? |
Abstract | The objective of this prospective cohort study was to evaluate the therapeutic efficacy and safety of ultrasound-guided high-intensity focussed ultrasound (HIFU) in the treatment of uterine fibroids. Twenty premenopausal women with symptomatic fibroids underwent ultrasound-guided HIFU therapy. Twenty-two fibroids with a median baseline volume of 127.0 cm3 (range 18.5–481.2 cm3) were treated. The percentages fibroid volume reduction were 46.9 (range −8.8–73.1) at 1-month, 57.4 (−51.5–95.2) at 3-month, 60.1 (−18.9–97.8) at 6-month and 75.9 (−33.7–99.3) at 12-month, after treatment. The modified Uterine Fibroid Symptom and Quality of Life (UFS-QOL) scores were reduced by 40.7% (0–59.3%) at 3-month, 45.5% (0–70.4%) at 6-month and 44.9% (0–71.4%) at 12-month after treatment. Three patients required subsequent surgical interventions. No significant complications were encountered. Ultrasound-guided HIFU appears to be effective and safe for the treatment of symptomatic uterine fibroids in selected patients. |
Persistent Identifier | http://hdl.handle.net/10722/272831 |
ISSN | 2023 Impact Factor: 0.9 2023 SCImago Journal Rankings: 0.390 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Cheung, VYT | - |
dc.contributor.author | Lam, TPW | - |
dc.contributor.author | Jenkins, CR | - |
dc.contributor.author | Lam, SW | - |
dc.contributor.author | Cheung, GKI | - |
dc.contributor.author | Chan, SSY | - |
dc.contributor.author | Choi, WK | - |
dc.date.accessioned | 2019-08-06T09:17:23Z | - |
dc.date.available | 2019-08-06T09:17:23Z | - |
dc.date.issued | 2019 | - |
dc.identifier.citation | Journal of Obstetrics and Gynaecology, 2019, v. 39, p. 833-839 | - |
dc.identifier.issn | 0144-3615 | - |
dc.identifier.uri | http://hdl.handle.net/10722/272831 | - |
dc.description.abstract | The objective of this prospective cohort study was to evaluate the therapeutic efficacy and safety of ultrasound-guided high-intensity focussed ultrasound (HIFU) in the treatment of uterine fibroids. Twenty premenopausal women with symptomatic fibroids underwent ultrasound-guided HIFU therapy. Twenty-two fibroids with a median baseline volume of 127.0 cm3 (range 18.5–481.2 cm3) were treated. The percentages fibroid volume reduction were 46.9 (range −8.8–73.1) at 1-month, 57.4 (−51.5–95.2) at 3-month, 60.1 (−18.9–97.8) at 6-month and 75.9 (−33.7–99.3) at 12-month, after treatment. The modified Uterine Fibroid Symptom and Quality of Life (UFS-QOL) scores were reduced by 40.7% (0–59.3%) at 3-month, 45.5% (0–70.4%) at 6-month and 44.9% (0–71.4%) at 12-month after treatment. Three patients required subsequent surgical interventions. No significant complications were encountered. Ultrasound-guided HIFU appears to be effective and safe for the treatment of symptomatic uterine fibroids in selected patients. | - |
dc.language | eng | - |
dc.publisher | Taylor & Francis: STM, Behavioural Science and Public Health Titles. The Journal's web site is located at http://informahealthcare.com/journal/jog | - |
dc.relation.ispartof | Journal of Obstetrics and Gynaecology | - |
dc.rights | This is an electronic version of an article published in [include the complete citation information for the final version of the article as published in the print edition of the journal]. [JOURNAL TITLE] is available online at: http://www.informaworld.com/smpp/ with the open URL of your article. | - |
dc.subject | Fibroid | - |
dc.subject | high-intensity focussed ultrasound | - |
dc.subject | ultrasound-guided | - |
dc.title | Efficacy and safety of ultrasound-guided high-intensity focused ultrasound for uterine fibroids: a preliminary experience | - |
dc.type | Article | - |
dc.identifier.email | Cheung, VYT: vytc@hku.hk | - |
dc.identifier.email | Lam, SW: bhgfhgh@hku.hk | - |
dc.identifier.email | Choi, WK: wkchoi@hkucc.hku.hk | - |
dc.identifier.authority | Cheung, VYT=rp01323 | - |
dc.identifier.authority | Lam, SW=rp01837 | - |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1080/01443615.2019.1581740 | - |
dc.identifier.pmid | 31006301 | - |
dc.identifier.scopus | eid_2-s2.0-85064610557 | - |
dc.identifier.hkuros | 300524 | - |
dc.identifier.volume | 39 | - |
dc.identifier.spage | 833 | - |
dc.identifier.epage | 839 | - |
dc.identifier.isi | WOS:000469530300001 | - |
dc.publisher.place | United Kingdom | - |
dc.identifier.issnl | 0144-3615 | - |